Reports
Reports
Sale
Regulatory Support for Advanced Computational Methods to Affect the Market Landscape Significantly
In August 2023, biosimulation company Certara’s division Simcyp Group received two new grants from the United States Food and Drug Administration (FDA) with the aim of expanding its innovative predictive models for drug virtual bioequivalence (VBE) studies and creating a formulation toolbox for topically applied drugs. This collaboration with the FDA will facilitate the development of model-informed approaches and is likely to ensure faster and more cost-effective development of novel drugs as well as complex generics. The rising regulatory support towards the integration of advanced computational methods in drug safety and efficacy evaluations is anticipated to bolster market growth in the coming years.
Increased Investment to Meet Rising Computational Biology Market Demand
There is a growing recognition of the importance and potential of computational biology, which is attracting significant investments from institutional investors, private donors, and venture capitalists. For instance, in November 2023, Carnegie Mellon University's Computational Biology Department received an investment of USD 25 million from the university's trustees. The funding was intended to be used in establishing an endowment, supporting the program's strategic priorities and infrastructure development. Such financial backing in the field of computational biology is poised to promote innovation and the development of new technologies, which will ultimately impact market growth.
Computational Biology Market Size
Computational Biology Market Growth
Computational Biology Market Trends
Computational Biology Market Share
Computational Biology Regional Analysis
Computational Biology Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Computational Biology Market Overview
3.1 Global Computational Biology Market Historical Value (2017-2023)
3.2 Global Computational Biology Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Computational Biology Market Landscape*
5.1 Global Computational Biology: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Computational Biology: Product Landscape
5.2.1 Analysis by Services
6 Global Computational Biology Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Environmental
6.3.3 Social
6.3.4 Technological
6.3.5 Ethical
6.3.6 Legal
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Computational Biology Market Segmentation (2017-2032)
7.1 Global Computational Biology Market (2017-2032) by Services
7.1.1 Market Overview
7.1.2 On-Premises
7.1.3 Cloud-Based
7.2 Global Computational Biology Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Genomics and Genetics
7.2.3 Drug Discovery and Development
7.2.4 Others
7.3 Global Computational Biology Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Academics
7.3.3 Industry
7.3.4 Commercial
7.4 Global Computational Biology Market (2017-2032) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Computational Biology Market (2017-2032)
8.1 North America Computational Biology Market (2017-2032) by Services
8.1.1 Market Overview
8.1.2 On-Premises
8.1.3 Cloud-Based
8.2 North America Computational Biology Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Genomics and Genetics
8.2.3 Drug Discovery and Development
8.2.4 Others
8.3 North America Computational Biology Market (2017-2032) by Country
8.3.1 United States of America
8.3.2 Canada
9 Europe Computational Biology Market (2017-2032)
9.1 Europe Computational Biology Market (2017-2032) by Services
9.1.1 Market Overview
9.1.2 On-Premises
9.1.3 Cloud-Based
9.2 Europe Computational Biology Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Genomics and Genetics
9.2.3 Drug Discovery and Development
9.2.4 Others
9.3 Europe Computational Biology Market (2017-2032) by Country
9.3.1 United Kingdom
9.3.2 Germany
9.3.3 France
9.3.4 Italy
9.3.5 Others
10 Asia Pacific Computational Biology Market (2017-2032)
10.1 Asia Pacific Computational Biology Market (2017-2032) by Services
10.1.1 Market Overview
10.1.2 On-Premises
10.1.3 Cloud-Based
10.2 Asia-Pacific Computational Biology Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Genomics and Genetics
10.2.3 Drug Discovery and Development
10.2.4 Others
10.3 Asia Pacific Computational Biology Market (2017-2032) by Country
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 ASEAN
10.3.5 Australia
10.3.6 Others
11 Latin America Computational Biology Market (2017-2032)
11.1 Latin America Computational Biology Market (2017-2032) by Services
11.1.1 Market Overview
11.1.2 On-Premises
11.1.3 Cloud-Based
11.2 Latin America Computational Biology Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Genomics and Genetics
11.2.3 Drug Discovery and Development
11.2.4 Others
11.3 Latin America Computational Biology Market (2017-2032) by Country
11.3.1 Brazil
11.3.2 Argentina
11.3.3 Mexico
11.3.4 Others
12 Middle East and Africa Computational Biology Market (2017-2032)
12.1 Middle East and Africa Computational Biology Market (2017-2032) by Services
12.1.1 Market Overview
12.1.2 On-Premises
12.1.3 Cloud-Based
12.2 Middle East and Africa Computational Biology Market (2017-2032) by Application
12.2.1 Market Overview
12.2.2 Genomics and Genetics
12.2.3 Drug Discovery and Development
12.2.4 Others
12.3 Middle East and Africa Computational Biology Market (2017-2032) by Country
12.3.1 Saudi Arabia
12.3.2 United Arab Emirates
12.3.3 Nigeria
12.3.4 South Africa
12.3.5 Others
13 Funding and Investment Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Strategic Initiatives
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership and Collaborations
14.3 Analysis by Joint Ventures
14.4 Analysis by Leading Players
14.5 Analysis by Geography
15 Supplier Landscape
15.1 Market Share Analysis, By Region (Top 5 Companies)
15.1.1 Market Share Analysis: Global
15.1.2 Market Share Analysis: North America
15.1.3 Market Share Analysis: Europe
15.1.4 Market Share Analysis: Asia-Pacific
15.1.5 Market Share Analysis: Others
15.2 Chemical Computing Group
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Dassault Systèmes S.E .
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Certara, Inc .
15.4.1 Product Portfolio
15.4.2 Demographic Reach and Achievements
15.4.3 Mergers and Acquisitions
15.4.4 Certifications
15.5 Instem plc
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Compugen
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Genedata
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 OKOGAWA DENKI KABUSHIKI KAISHA
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 STRAND LIFE SCIENCES PRIVATE LIMITED
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Schrödinger, Inc .
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
15.11 SimulationPlus
15.11.1 Financial Analysis
15.11.2 Product Portfolio
15.11.3 Demographic Reach and Achievements
15.11.4 Mergers and Acquisitions
15.11.5 Certifications
16 Global Computational Biology Market – Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.